New Covered Stent (Willis) for the Endovascular Reconstruction of Intracranial Vessel Wall Defects Registry

NCT02820779 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2016-07-01

No results posted yet for this study

Summary

The purpose of this study is to evaluate the effectiveness, long-term safety and explore the safety and efficacy factors WILLIS™ intracranial stent graft system in clinical applications.

Conditions

  • Aneurysm, Intracranial
  • Carotid-Cavernous Sinus Fistula

Interventions

DEVICE

WILLIS

WILLIS® intracranial stent graft system is composed of the stent, delivery system, cobalt-based alloy stent and PTFE graft. It can effectively shunt the blood flow and keep it off of the aneurysm wall.

Sponsors & Collaborators

  • First Affiliated Hospital of Harbin Medical University

    collaborator OTHER
  • The Second Affiliated Hospital of Harbin Medical University

    collaborator OTHER
  • Qilu Hospital of Shandong University

    collaborator OTHER
  • Shanghai Tongji Hospital, Tongji University School of Medicine

    collaborator OTHER
  • Nanfang Hospital, Southern Medical University

    collaborator OTHER
  • Tang-Du Hospital

    collaborator OTHER
  • West China Hospital

    collaborator OTHER
  • The First Affiliated Hospital of Zhengzhou University

    collaborator OTHER
  • Shaanxi Provincial People's Hospital

    collaborator OTHER
  • Shandong Provincial Hospital

    collaborator OTHER_GOV
  • First Affiliated Hospital of Xinjiang Medical University

    collaborator OTHER
  • Xuanwu Hospital, Beijing

    lead OTHER

Principal Investigators

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2019-05-31
Completion
2019-05-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02820779 on ClinicalTrials.gov